ArticleNPJ science of food2026
Global burden and trends of cardiovascular disease attributable to low vegetable intake: a global burden of disease 1990-2021 analysis and projection to 2035.
Article in NPJ science of food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cardiovascular disease (CVD) remains among the leading causes of death and disability worldwide. Although diet is a modifiable risk factor, the specific contribution of low vegetable intake to CVD burden has not been fully quantified. We assessed the burden of CVD attributable to a diet low in vegetables from 1990 to 2021 and projected trends up to 2035 using data from the Global Burden of Disease (GBD) 2021 study. Age-standardized mortality rates (ASMRs) and estimated annual percentage changes were calculated to describe temporal trends. Bayesian age-period-cohort models were used to predict future trajectories up to 2035. Analyses were stratified by sex, age group, CVD subtype, and sociodemographic index (SDI) quintile. Globally, ASMR declined, but absolute deaths increased. The burden was highest in low- to moderate-SDI regions, particularly in South Asia. Men aged ≥55 years were most affected, and hypertensive heart disease was the leading subtype. Projections indicate that global ASMR will continue to decline gradually through 2035. Age-standardized mortality has declined globally over the past three decades; however, the absolute burden continues to rise. These findings highlight the importance of targeted dietary interventions and public health policies.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.